Y Intercept (Hong Kong) LTD Albemarle Corp Transaction History

Y Intercept (Hong Kong) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$214.02 - $325.38 $380,313 - $578,200	-1,777 Closed	0 $0
Q3 2022 Feb 14, 2023	SELL	$195.82 - $307.05 $324,473 - $508,781	-1,657 Reduced 48.25%	1,777 $469,000
Q2 2022 Aug 08, 2022	BUY	$187.76 - $270.92 $644,767 - $930,339	3,434 New	3,434 $718,000
Q1 2022 May 16, 2022	SELL	$172.09 - $246.0 $464,987 - $664,692	-2,702 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$214.16 - $283.8 $578,660 - $766,827	2,702 New	2,702 $632,000
Q2 2021 Aug 12, 2021	SELL	$143.7 - $176.01 $562,154 - $688,551	-3,912 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$140.69 - $185.25 $550,379 - $724,698	3,912 New	3,912 $569,000

953

109M

6.7M

10.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $11.1B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.